• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾透明细胞癌中潜在生物标志物和治疗靶点的筛选:来自生物信息学分析的证据

Screening of possible biomarkers and therapeutic targets in kidney renal clear cell carcinoma: Evidence from bioinformatic analysis.

作者信息

Peng Longfei, Cao Zhangjun, Wang Qi, Fang Lu, Yan Songbai, Xia Dian, Wang Jinyou, Bi Liangkuan

机构信息

Department of Urology, Second Hospital of Anhui Medical University, Hefei, China.

出版信息

Front Oncol. 2022 Oct 13;12:963483. doi: 10.3389/fonc.2022.963483. eCollection 2022.

DOI:10.3389/fonc.2022.963483
PMID:36313709
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9606658/
Abstract

Renal cell carcinoma (RCC), as one of the most common urological malignancies, has many histologic and molecular subtypes, among which clear cell renal cell carcinoma (ccRCC) is one of the most common causes of tumor-related deaths. However, the molecular mechanism of ccRCC remains unclear. In order to identify the candidate genes that may exist in the occurrence and development of ccRCC, microarray datasets GSE6344, GSE16441, GSE36895, GSE53757 and GSE76351 had been downloaded from Gene Expression Omnibus (GEO) database. Apart from that, the differentially expressed genes (DEGs) were screened through Bioinformatics & Evolutionary Genomics. In addition, the protein-protein interaction network (PPI) was constructed, and the module analysis was performed using STRING and Cytoscape. By virtue of DAVID online database, GO/KEGG enrichment analysis of DEGs was performed. Consequently, a total of 118 DEGs were screened, including 24 up-regulated genes and 94 down-regulated genes. The plug-in MCODE of Cytoscape was adopted to analyze the most significant modules of DEGs. What's more, the genes with degree greater than 10 in DEGs were selected as the hub genes. The overall survival (OS) and disease progression free survival (DFS) of 9 hub genes were analyzed through GEPIA2 online platform. As shown by the survival analysis, SLC34A1, SLC12A3, SLC12A1, PLG, and ENO2 were closely related to the OS of ccRCC, whereas SLC34A1 and LOX were closely related to DFS. Among 11 SLC members, 6 SLC members were highly expressed in non-cancerous tissues (SLC5A2, SLC12A1, SLC12A3, SLC34A1, SLC34A2, SLC34A3). Besides, SLC12A5 and SLC12A7 were highly expressed in ccRCC. Furthermore, SLC12A1-A7, SLC34A1 and SLC34A3 were closely related to OS, whereas SLC12A2/A4/A6/A7 and SLC34A1/A3 were closely related to DFS. In addition, 5 algorithms were used to analyze hub genes, the overlapping genes were AQP2 and KCNJ1. To sum up, hub gene can help us understand the molecular mechanism of the occurrence and development of ccRCC, thereby providing a theoretical basis for the diagnosis and targeted therapy of ccRCC.

摘要

肾细胞癌(RCC)是最常见的泌尿系统恶性肿瘤之一,有多种组织学和分子亚型,其中透明细胞肾细胞癌(ccRCC)是肿瘤相关死亡的最常见原因之一。然而,ccRCC的分子机制仍不清楚。为了鉴定可能在ccRCC发生和发展中存在的候选基因,从基因表达综合数据库(GEO)下载了微阵列数据集GSE6344、GSE16441、GSE36895、GSE53757和GSE76351。除此之外,通过生物信息学与进化基因组学筛选差异表达基因(DEG)。此外,构建了蛋白质-蛋白质相互作用网络(PPI),并使用STRING和Cytoscape进行模块分析。借助DAVID在线数据库,对DEG进行GO/KEGG富集分析。结果,共筛选出118个DEG,包括24个上调基因和94个下调基因。采用Cytoscape的插件MCODE分析DEG中最显著的模块。此外,将DEG中度数大于10的基因选为枢纽基因。通过GEPIA2在线平台分析9个枢纽基因的总生存期(OS)和无疾病进展生存期(DFS)。生存分析表明,SLC34A1、SLC12A3、SLC12A1、PLG和ENO2与ccRCC的OS密切相关,而SLC34A1和LOX与DFS密切相关。在11个溶质载体(SLC)成员中,6个SLC成员在非癌组织中高表达(SLC5A2、SLC12A1、SLC12A3、SLC34A1、SLC34A2、SLC34A3)。此外,SLC12A5和SLC12A7在ccRCC中高表达。此外,SLC12A1-A7、SLC34A1和SLC34A3与OS密切相关,而SLC12A2/A4/A6/A7和SLC34A1/A3与DFS密切相关。此外,使用5种算法分析枢纽基因,重叠基因是水通道蛋白2(AQP2)和内向整流钾通道蛋白1(KCNJ1)。综上所述,枢纽基因有助于我们了解ccRCC发生和发展的分子机制,从而为ccRCC的诊断和靶向治疗提供理论依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2155/9606658/dfce5b0057bc/fonc-12-963483-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2155/9606658/0e6030ebdacd/fonc-12-963483-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2155/9606658/b3db0dd564ff/fonc-12-963483-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2155/9606658/5a483bf55c69/fonc-12-963483-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2155/9606658/b2afd07208c5/fonc-12-963483-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2155/9606658/7a81aebc061a/fonc-12-963483-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2155/9606658/dfce5b0057bc/fonc-12-963483-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2155/9606658/0e6030ebdacd/fonc-12-963483-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2155/9606658/b3db0dd564ff/fonc-12-963483-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2155/9606658/5a483bf55c69/fonc-12-963483-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2155/9606658/b2afd07208c5/fonc-12-963483-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2155/9606658/7a81aebc061a/fonc-12-963483-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2155/9606658/dfce5b0057bc/fonc-12-963483-g006.jpg

相似文献

1
Screening of possible biomarkers and therapeutic targets in kidney renal clear cell carcinoma: Evidence from bioinformatic analysis.肾透明细胞癌中潜在生物标志物和治疗靶点的筛选:来自生物信息学分析的证据
Front Oncol. 2022 Oct 13;12:963483. doi: 10.3389/fonc.2022.963483. eCollection 2022.
2
Bioinformatic analysis identifies potentially key differentially expressed genes in oncogenesis and progression of clear cell renal cell carcinoma.生物信息学分析确定了在透明细胞肾细胞癌发生和进展中潜在的关键差异表达基因。
PeerJ. 2019 Nov 26;7:e8096. doi: 10.7717/peerj.8096. eCollection 2019.
3
Bioinformatics analysis of C3 and CXCR4 demonstrates their potential as prognostic biomarkers in clear cell renal cell carcinoma (ccRCC).C3 和 CXCR4 的生物信息学分析表明它们可能成为透明细胞肾细胞癌 (ccRCC) 的预后生物标志物。
BMC Cancer. 2021 Jul 15;21(1):814. doi: 10.1186/s12885-021-08525-w.
4
Identification of potential biomarkers and candidate therapeutic drugs for clear cell renal cell carcinoma by bioinformatic analysis and reverse network pharmacology.通过生物信息学分析和反向网络药理学鉴定透明细胞肾细胞癌的潜在生物标志物和候选治疗药物。
Medicine (Baltimore). 2023 Sep 1;102(35):e34929. doi: 10.1097/MD.0000000000034929.
5
Bioinformatics analysis and verification of gene targets for renal clear cell carcinoma.生物信息学分析和验证肾透明细胞癌的基因靶点。
Comput Biol Chem. 2021 Jun;92:107453. doi: 10.1016/j.compbiolchem.2021.107453. Epub 2021 Feb 9.
6
Screening of differential gene expression patterns through survival analysis for diagnosis, prognosis and therapies of clear cell renal cell carcinoma.通过生存分析筛选差异基因表达模式,用于透明细胞肾细胞癌的诊断、预后和治疗。
PLoS One. 2024 Sep 30;19(9):e0310843. doi: 10.1371/journal.pone.0310843. eCollection 2024.
7
Prediction and analysis of novel key genes ITGAX, LAPTM5, SERPINE1 in clear cell renal cell carcinoma through bioinformatics analysis.通过生物信息学分析对透明细胞肾细胞癌中新型关键基因ITGAX、LAPTM5、SERPINE1进行预测与分析
PeerJ. 2021 Apr 20;9:e11272. doi: 10.7717/peerj.11272. eCollection 2021.
8
Integrated bioinformatics analysis for the identification of potential key genes affecting the pathogenesis of clear cell renal cell carcinoma.用于鉴定影响透明细胞肾细胞癌发病机制的潜在关键基因的综合生物信息学分析
Oncol Lett. 2020 Aug;20(2):1573-1584. doi: 10.3892/ol.2020.11703. Epub 2020 Jun 5.
9
Identification of hub genes associated with outcome of clear cell renal cell carcinoma.与透明细胞肾细胞癌预后相关的枢纽基因的鉴定
Oncol Lett. 2020 Apr;19(4):2846-2860. doi: 10.3892/ol.2020.11389. Epub 2020 Feb 12.
10
Identification of Core Genes Involved in the Metastasis of Clear Cell Renal Cell Carcinoma.肾透明细胞癌转移相关核心基因的鉴定
Cancer Manag Res. 2020 Dec 30;12:13437-13449. doi: 10.2147/CMAR.S276818. eCollection 2020.

引用本文的文献

1
Urinary exosomes as promising biomarkers for early kidney disease detection.尿外泌体作为早期肾病检测的有前景的生物标志物。
Am J Clin Exp Urol. 2025 Feb 15;13(1):1-19. doi: 10.62347/DAKE5842. eCollection 2025.
2
ETV4‑mediated transcriptional activation of SLC12A5 exacerbates ferroptosis resistance and glucose metabolism reprogramming in breast cancer cells.ETV4 介导的 SLC12A5 转录激活加剧乳腺癌细胞的铁死亡抵抗和葡萄糖代谢重编程。
Mol Med Rep. 2024 Dec;30(6). doi: 10.3892/mmr.2024.13341. Epub 2024 Sep 27.
3
Screening of differential gene expression patterns through survival analysis for diagnosis, prognosis and therapies of clear cell renal cell carcinoma.

本文引用的文献

1
Aquaporins in Cancer Biology.癌症生物学中的水通道蛋白
Front Oncol. 2022 Jun 29;12:782829. doi: 10.3389/fonc.2022.782829. eCollection 2022.
2
Abnormal expression and the significant prognostic value of aquaporins in clear cell renal cell carcinoma.水通道蛋白在肾透明细胞癌中的异常表达及其显著的预后价值。
PLoS One. 2022 Mar 4;17(3):e0264553. doi: 10.1371/journal.pone.0264553. eCollection 2022.
3
Functional succinate dehydrogenase deficiency is a common adverse feature of clear cell renal cancer.功能性琥珀酸脱氢酶缺乏是肾透明细胞癌的常见不良特征。
通过生存分析筛选差异基因表达模式,用于透明细胞肾细胞癌的诊断、预后和治疗。
PLoS One. 2024 Sep 30;19(9):e0310843. doi: 10.1371/journal.pone.0310843. eCollection 2024.
4
Multiomics combined with single-cell analysis shows that mitophagy-related genes could accurately predict the prognosis of patients with clear cell renal cell carcinoma.多组学与单细胞分析相结合表明,线粒体自噬相关基因能够准确预测肾透明细胞癌患者的预后。
Transl Cancer Res. 2024 Feb 29;13(2):819-832. doi: 10.21037/tcr-23-1765. Epub 2024 Feb 23.
Proc Natl Acad Sci U S A. 2021 Sep 28;118(39). doi: 10.1073/pnas.2106947118.
4
Urine LOX-1 and Volatilome as Promising Tools towards the Early Detection of Renal Cancer.尿液LOX-1和挥发性有机化合物组作为早期检测肾癌的有前景的工具。
Cancers (Basel). 2021 Aug 21;13(16):4213. doi: 10.3390/cancers13164213.
5
SDHB Suppresses the Tumorigenesis and Development of ccRCC by Inhibiting Glycolysis.SDHB通过抑制糖酵解来抑制ccRCC的肿瘤发生和发展。
Front Oncol. 2021 May 19;11:639408. doi: 10.3389/fonc.2021.639408. eCollection 2021.
6
The Role of Epigenetics in the Progression of Clear Cell Renal Cell Carcinoma and the Basis for Future Epigenetic Treatments.表观遗传学在透明细胞肾细胞癌进展中的作用及未来表观遗传治疗的基础
Cancers (Basel). 2021 Apr 25;13(9):2071. doi: 10.3390/cancers13092071.
7
A guide to plasma membrane solute carrier proteins.质膜溶质载体蛋白指南。
FEBS J. 2021 May;288(9):2784-2835. doi: 10.1111/febs.15531. Epub 2020 Sep 18.
8
The burden of kidney cancer and its attributable risk factors in 195 countries and territories, 1990-2017.1990-2017 年,195 个国家和地区的肾癌负担及其可归因危险因素。
Sci Rep. 2020 Aug 17;10(1):13862. doi: 10.1038/s41598-020-70840-2.
9
Genetic Alterations in Renal Cancers: Identification of The Mechanisms Underlying Cancer Initiation and Progression and of Therapeutic Targets.肾癌中的基因改变:确定癌症起始和进展的潜在机制以及治疗靶点。
Medicines (Basel). 2020 Jul 29;7(8):44. doi: 10.3390/medicines7080044.
10
Risk Prediction Models for Kidney Cancer: A Systematic Review.肾癌风险预测模型:系统评价。
Eur Urol Focus. 2021 Nov;7(6):1380-1390. doi: 10.1016/j.euf.2020.06.024. Epub 2020 Jul 14.